Literature DB >> 15550017

The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry.

M Monreal1, A K Kakkar, J A Caprini, R Barba, F Uresandi, R Valle, C Suarez, R Otero.   

Abstract

BACKGROUND: The history of venous thromboembolism (VTE), and the rationale for thromboprophylaxis in surgical patients are well understood. The situation is less clear for acutely ill medical patients.
OBJECTIVES: To compare the clinical presentation of VTE and clinical outcomes of immobile acutely ill medical patients with surgical patients. PATIENTS: RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) is a Spanish registry of consecutively enrolled patients with objectively confirmed, symptomatic acute VTE. In this analysis, clinical characteristics of patients, details of anticoagulant therapy, and outcomes of all enrolled acutely ill medical patients with immobility >/= 4 days, and surgical patients are included.
RESULTS: Of 6160 patients enrolled up to December 2003, 756 (12%) were acutely ill medical patients with immobility >/= 4 days, and 884 (14%) were surgical patients who developed VTE within 2 months of surgical intervention. Only 28% of acutely ill medical patients had received thromboprophylaxis, compared with 67% of surgical patients. During the 3-month follow-up period, both fatal pulmonary embolism (PE) and fatal bleeding occurred more frequently in acutely ill medical patients. Immobility in acutely ill medical patients, cancer, and PE were associated with a significantly higher risk of fatal PE or bleeding.
CONCLUSIONS: In patients treated for VTE, the incidences of fatal PE, fatal bleeding, and major bleeding were significantly higher in acutely ill medical patients compared with surgical patients. Given the low percentage of acutely ill medical patients who had received thromboprophylaxis, increasing its use appropriately may reduce the incidence of VTE and associated complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550017     DOI: 10.1111/j.1538-7836.2004.01012.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  28 in total

Review 1.  Review of race/ethnicity in non vitamin K antagonist oral anticoagulants clinical trials.

Authors:  Larry R Jackson; Eric D Peterson; Eze Okeagu; Kevin Thomas
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

Review 2.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

3.  Venous thromboembolism in COPD hospitalized patients.

Authors:  Raquel Barba; Antonio Zapatero; Javier Marco; Juan E Losa; Susana Plaza; Jose Manuel Casas; Jesús Canora
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

4.  Perioperative risk factors for death among patients with symptomatic pulmonary thromboembolism.

Authors: 
Journal:  J Anesth       Date:  2017-03-09       Impact factor: 2.078

Review 5.  Has time come for the use of direct oral anticoagulants in the extended prophylaxis of venous thromboembolism in acutely ill medical patients? Yes.

Authors:  Walter Ageno
Journal:  Intern Emerg Med       Date:  2017-08-14       Impact factor: 3.397

6.  Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease.

Authors:  Justina J Sam; Charles N Bernstein; Roshan Razik; Reka Thanabalan; Geoffrey C Nguyen
Journal:  Dig Dis Sci       Date:  2012-10-07       Impact factor: 3.199

7.  Impact of Thrombus Sidedness on Presentation and Outcomes of Patients with Proximal Lower Extremity Deep Vein Thrombosis.

Authors:  Behnood Bikdeli; Babak Sharif-Kashani; Bavand Bikdeli; Reina Valle; Conxita Falga; Antoni Riera-Mestre; Lucia Mazzolai; Peter Verhamme; Philip S Wells; Juan Francisco Sánchez Muñoz Torrero; Luciano Lopez-Jiménez; Manuel Monreal
Journal:  Semin Thromb Hemost       Date:  2018-01-12       Impact factor: 4.180

8.  Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country.

Authors:  Ambarish Pandey; Nivedita Patni; Mansher Singh; Randeep Guleria
Journal:  Vasc Health Risk Manag       Date:  2009-08-06

9.  Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts.

Authors:  Greg Maynard; Jason Stein
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

10.  Prevention and treatment of venous thromboembolism in the elderly patient.

Authors:  Enrico Tincani; Mark A Crowther; Fabrizio Turrini; Domenico Prisco
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.